The Chronic Lower Back Pain Drugs Market was valued at around USD 2.77 billion in 2024 and is projected to reach USD 4.61 billion by 2033, growing at a 6.4% CAGR, driven by ageing populations and demand for safer, non‑opioid pain treatments . North America currently leads (~45% share), while Asia‑Pacific is the fastest‑growing region, as NSAIDs dominate and innovations such as nerve‑t... https://www.datamintelligence.com/research-report/chronic-lower-back-pain-drugs-market